{"id":"https://openalex.org/W1987196669","doi":"https://doi.org/10.1016/j.jhep.2013.05.045","title":"Liver as a target for oligonucleotide therapeutics","display_name":"Liver as a target for oligonucleotide therapeutics","alternate_titles":[],"publication_year":2013,"publication_date":"2013-06-12","ids":{"openalex":"https://openalex.org/W1987196669","doi":"https://doi.org/10.1016/j.jhep.2013.05.045","mag":"1987196669","pmid":"https://pubmed.ncbi.nlm.nih.gov/23770039"},"language":"en","primary_location":{"id":"doi:10.1016/j.jhep.2013.05.045","doi":"https://doi.org/10.1016/j.jhep.2013.05.045","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jhep.2013.05.045","pdf_url":null,"source":{"id":"https://openalex.org/S83651209","display_name":"Journal of Hepatology","issn_l":"0168-8278","issn":["0168-8278","1600-0641"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hepatology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1987196669"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.jhep.2013.05.045","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000034424","display_name":"Alfica Sehgal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311141","display_name":"Alnylam Pharmaceuticals (United States)","ror":"https://ror.org/00thr3w71","country_code":"US","type":"company","lineage":["https://openalex.org/I145311141"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Alfica Sehgal","raw_affiliation_strings":["Alnylam Pharmaceuticals Inc., Cambridge, MA 02142, USA. Electronic address: asehgal@alnylam.com","Alnylam Pharmaceuticals Inc., Cambridge, MA 02142, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alnylam Pharmaceuticals Inc., Cambridge, MA 02142, USA. Electronic address: asehgal@alnylam.com","institution_ids":["https://openalex.org/I145311141"]},{"raw_affiliation_string":"Alnylam Pharmaceuticals Inc., Cambridge, MA 02142, USA","institution_ids":["https://openalex.org/I145311141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079865402","display_name":"Akshay K. Vaishnaw","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311141","display_name":"Alnylam Pharmaceuticals (United States)","ror":"https://ror.org/00thr3w71","country_code":"US","type":"company","lineage":["https://openalex.org/I145311141"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Akshay Vaishnaw","raw_affiliation_strings":["Alnylam Pharmaceuticals Inc., Cambridge, MA 02142, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alnylam Pharmaceuticals Inc., Cambridge, MA 02142, USA","institution_ids":["https://openalex.org/I145311141"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112445490","display_name":"Kevin J. Fitzgerald","orcid":"https://orcid.org/0009-0005-7004-0483","observed_orcids":["https://orcid.org/0009-0005-7004-0483"]},"institutions":[{"id":"https://openalex.org/I145311141","display_name":"Alnylam Pharmaceuticals (United States)","ror":"https://ror.org/00thr3w71","country_code":"US","type":"company","lineage":["https://openalex.org/I145311141"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin Fitzgerald","raw_affiliation_strings":["Alnylam Pharmaceuticals Inc., Cambridge, MA 02142, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alnylam Pharmaceuticals Inc., Cambridge, MA 02142, USA","institution_ids":["https://openalex.org/I145311141"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5000034424"],"corresponding_institution_ids":["https://openalex.org/I145311141"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":{"value":5500,"currency":"USD","value_usd":5500},"fwci":3.7304,"has_fulltext":false,"cited_by_count":121,"citation_normalized_percentile":{"value":0.9512657,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"59","issue":"6","first_page":"1354","last_page":"1359"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10432","display_name":"DNA and Nucleic Acid Chemistry","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oligonucleotide-therapeutics","display_name":"oligonucleotide therapeutics","score":0.9769999980926514},{"id":"https://openalex.org/keywords/liver-targeted-drug-delivery","display_name":"liver-targeted drug delivery","score":0.8820000290870667},{"id":"https://openalex.org/keywords/sirna","display_name":"siRNA","score":0.7250000238418579},{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.9470000267028809},{"id":"https://openalex.org/keywords/mirna-inhibitors","display_name":"miRNA inhibitors","score":0.5440000295639038},{"id":"https://openalex.org/keywords/microrna-mimics","display_name":"miRNA mimics","score":0.8180000185966492},{"id":"https://openalex.org/keywords/rna-interference","display_name":"RNA interference","score":0.8059999942779541},{"id":"https://openalex.org/keywords/ribozymes","display_name":"ribozymes","score":0.6909999847412109},{"id":"https://openalex.org/keywords/aptamers","display_name":"aptamers","score":0.9990000128746033},{"id":"https://openalex.org/keywords/intracellular-delivery","display_name":"intracellular delivery","score":0.746999979019165},{"id":"https://openalex.org/keywords/liver-disease","display_name":"liver disease","score":0.42100000381469727}],"concepts":[{"id":"https://openalex.org/C129312508","wikidata":"https://www.wikidata.org/wiki/Q133686","display_name":"Oligonucleotide","level":3,"score":0.7226052284240723},{"id":"https://openalex.org/C119056186","wikidata":"https://www.wikidata.org/wiki/Q1431332","display_name":"Gene silencing","level":3,"score":0.6271041631698608},{"id":"https://openalex.org/C76346623","wikidata":"https://www.wikidata.org/wiki/Q205858","display_name":"Ribozyme","level":4,"score":0.6268838047981262},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6139965057373047},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5835887789726257},{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.5732815861701965},{"id":"https://openalex.org/C166703698","wikidata":"https://www.wikidata.org/wiki/Q201993","display_name":"RNA interference","level":4,"score":0.5700129866600037},{"id":"https://openalex.org/C10679952","wikidata":"https://www.wikidata.org/wiki/Q5308937","display_name":"Druggability","level":3,"score":0.5388780236244202},{"id":"https://openalex.org/C22615655","wikidata":"https://www.wikidata.org/wiki/Q203221","display_name":"Small interfering RNA","level":4,"score":0.5279067158699036},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.5121521949768066},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.48701411485671997},{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.4693649113178253},{"id":"https://openalex.org/C24107716","wikidata":"https://www.wikidata.org/wiki/Q123619","display_name":"Nucleic acid","level":2,"score":0.4538593888282776},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.33722764253616333}],"mesh":[{"descriptor_ui":"D000075802","descriptor_name":"Angiopoietin-like Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000091303","descriptor_name":"Angiopoietin-Like Protein 3","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008107","descriptor_name":"Liver Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009841","descriptor_name":"Oligonucleotides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D042682","descriptor_name":"Angiopoietins","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jhep.2013.05.045","doi":"https://doi.org/10.1016/j.jhep.2013.05.045","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jhep.2013.05.045","pdf_url":null,"source":{"id":"https://openalex.org/S83651209","display_name":"Journal of Hepatology","issn_l":"0168-8278","issn":["0168-8278","1600-0641"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hepatology","raw_type":"journal-article"},{"id":"pmid:23770039","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23770039","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of hepatology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.jhep.2013.05.045","doi":"https://doi.org/10.1016/j.jhep.2013.05.045","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jhep.2013.05.045","pdf_url":null,"source":{"id":"https://openalex.org/S83651209","display_name":"Journal of Hepatology","issn_l":"0168-8278","issn":["0168-8278","1600-0641"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hepatology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309056","display_name":"Alnylam Pharmaceuticals","ror":"https://ror.org/00thr3w71"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1520348292","https://openalex.org/W1974266372","https://openalex.org/W1978600799","https://openalex.org/W1991920463","https://openalex.org/W2005377199","https://openalex.org/W2021445521","https://openalex.org/W2034649063","https://openalex.org/W2040955313","https://openalex.org/W2047043150","https://openalex.org/W2048251248","https://openalex.org/W2054610237","https://openalex.org/W2068919255","https://openalex.org/W2079175326","https://openalex.org/W2083910514","https://openalex.org/W2095151181","https://openalex.org/W2095995901","https://openalex.org/W2106465356","https://openalex.org/W2109559983","https://openalex.org/W2115311848","https://openalex.org/W2129441054","https://openalex.org/W2141191772","https://openalex.org/W2143743183","https://openalex.org/W2149896139","https://openalex.org/W2166005458","https://openalex.org/W2169218609","https://openalex.org/W2186925025","https://openalex.org/W2518874627","https://openalex.org/W2535551680","https://openalex.org/W2558547789","https://openalex.org/W2595873267","https://openalex.org/W2623007340","https://openalex.org/W4241557582"],"related_works":["https://openalex.org/W2524889252","https://openalex.org/W2914869182","https://openalex.org/W3125302792","https://openalex.org/W7167901357","https://openalex.org/W1881614320","https://openalex.org/W4230416897","https://openalex.org/W4282923968","https://openalex.org/W2792361713","https://openalex.org/W2039022578","https://openalex.org/W2051209985"],"abstract_inverted_index":{"Oligonucleotide-based":[0],"therapeutics":[1,37,100,305],"are":[2,28,40,176,367],"an":[3],"emerging":[4],"class":[5],"of":[6,56,70,154,170,192,212,246,273,289,335,358],"drugs":[7],"that":[8,96,106,115,120,126,306,354],"hold":[9],"the":[10,49,73,80,92,157,190,240,263,271,293,311,318,323,363],"promise":[11,309],"for":[12,19,87,162],"silencing":[13],"\"un-druggable\"":[14],"targets,thus":[15],"creating":[16],"unique":[17],"opportunities":[18],"innovative":[20],"medicines.":[21],"As":[22],"opposed":[23],"to":[24,30,34,63,164,200,231,236,284,369],"gene":[25,90,213,216],"therapy,":[26],"oligonucleotides":[27,142,290],"considered":[29],"be":[31,128,165],"more":[32],"akin":[33],"small":[35],"molecule":[36],"because":[38],"they":[39,83,366],"small,completely":[41],"synthetic":[42],"in":[43,91,178,189,218,249,322,329,362],"origin,":[44],"do":[45],"not":[46,352],"integrate":[47],"into":[48],"host":[50],"genome,and":[51],"have":[52,208,229,301,307],"a":[53,67,85,326,355],"defined":[54],"duration":[55],"therapeutic":[57],"activity":[58,175],"after":[59],"which":[60,196],"effects":[61],"recover":[62],"baseline.":[64],"They":[65],"offer":[66],"high":[68],"degree":[69,153],"specificity":[71],"at":[72,156,310],"genetic":[74],"level,":[75],"thereby":[76],"reducing":[77],"off-target":[78],"effects.At":[79],"same":[81],"time,":[82],"provide":[84],"strategy":[86],"targeting":[88,137],"any":[89],"genome,":[93],"including":[94,252],"transcripts":[95],"produce":[97],"mutated":[98],"proteins.Oligonucleotide-based":[99],"include":[101],"short":[102],"interfering":[103],"RNA":[104],"(siRNA),":[105],"degrade":[107],"target":[108,116,122,264],"mRNA":[109,133,135],"through":[110,130],"RISC":[111],"mediated":[112,132],"RNAi;":[113],"anti-miRs,":[114],"miRNAs;":[117],"miRNA":[118],"mimics,":[119],"regulate":[121],"mRNA;":[123],"antisense":[124],"oligonucleotides,":[125],"may":[127],"working":[129],"RNAseH":[131],"decay;":[134],"upregulation,by":[136],"long":[138],"non-coding":[139],"RNAs;":[140],"and":[141,172,194,215,221,242,275,298,333,345],"induced":[143],"alternative":[144],"splicing":[145],"[1].":[146],"All":[147],"these":[148,225,247],"approaches":[149],"require":[150],"some":[151],"minimal":[152],"homology":[155],"nucleic":[158,201],"acid":[159],"sequence":[160],"level":[161],"them":[163],"functional.":[166],"The":[167],"different":[168],"mechanisms":[169],"action":[171,256],"their":[173,255],"relevant":[174],"outlined":[177],"Fig.":[179],"1.":[180],"Besides":[181],"homology,RNA":[182],"secondary":[183],"structure":[184],"has":[185,238,291],"also":[186],"been":[187,209,239,292],"exploited":[188],"case":[191],"ribozymes":[193],"aptamers,":[195],"act":[197],"by":[198,371],"binding":[199],"acids":[202],"or":[203],"proteins,":[204,340],"respectively.":[205],"While":[206],"there":[207],"many":[210],"reports":[211],"knockdown":[214],"modulation":[217,370],"cell":[219,265],"lines":[220],"mice":[222],"with":[223,260,295],"all":[224],"methods,":[226],"very":[227],"few":[228],"advanced":[230],"clinical":[232,314],"stages.The":[233],"main":[234],"obstacle":[235],"date":[237],"safe":[241],"effective":[243],"intracellular":[244],"delivery":[245,288],"compounds":[248],"higher":[250],"species,":[251],"humans.":[253],"Indeed,":[254],"requires":[257],"direct":[258],"interaction":[259],"DNA/RNA":[261],"within":[262],"so":[266],"even":[267],"when":[268],"one":[269],"solves":[270],"issues":[272],"tissue":[274],"cellular":[276],"access,":[277],"intracellular/intranuclear":[278],"location":[279],"represents":[280],"yet":[281],"another":[282],"barrier":[283],"overcome.":[285],"To":[286],"date,hepatic":[287],"area":[294],"greatest":[296],"progress,":[297],"thus":[299],"we":[300],"focused":[302],"on":[303],"liver-targeted":[304],"shown":[308],"preclinical":[312],"and/or":[313],"level.The":[315],"liver":[316,364],"is":[317,350],"largest":[319],"internal":[320],"organ":[321],"body,":[324],"playing":[325],"central":[327],"role":[328],"metabolism,":[330],"detoxification,":[331],"synthesis,":[332],"secretion":[334],"major":[336],"plasma":[337],"proteins":[338],"(carrier":[339],"coagulation":[341],"factors,complement":[342],"components,":[343],"hormones,":[344],"apolipoproteins),and":[346],"iron":[347],"homeostasis.":[348],"It":[349],"therefore":[351],"surprising":[353],"large":[356],"number":[357],"disease":[359],"targets":[360],"reside":[361],"where":[365],"susceptible":[368],"oligonucleotide":[372],"therapies.":[373]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1987196669","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":13},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":17},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":16},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
